المؤلفون: Xin He (48101), Guangchao He (8194926), Zhaoxing Chu (7536365), Huanhuan Wu (339728), Junjie Wang (172690), Yiran Ge (8194932), Hui Shen (66625), Shan Zhang (431282), Jinxi Shan (11784280), Kewen Peng (8194929), Zhifeng Wei (11453658), Yi Zou (439002), Yungen Xu (1434802), Qihua Zhu (1555147)

مصطلحات موضوعية: Biochemistry, Medicine, Molecular Biology, Pharmacology, Biotechnology, Immunology, Cancer, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, unsatisfactory clinical efficacies, preliminary mechanistic studies, first inhibitor targeting, emerging evidence suggests, tumor immune escape, 144 nm ), selective ido1 inhibitors, first potent ido1, ido2 dual inhibitors, 2 dual inhibitors, selectively inhibiting ido1, 50 , 4t , inhibiting ido1, vivo <, vitro <, tumor immunotherapy, 28 nm, ido1 ic, synergistic effects, promising strategy

Relation: https://figshare.com/articles/journal_contribution/Discovery_of_the_First_Potent_IDO1_IDO2_Dual_Inhibitors_A_Promising_Strategy_for_Cancer_Immunotherapy/17113531

الاتاحة: https://doi.org/10.1021/acs.jmedchem.1c01305.s001

المؤلفون: Xin He (48101), Guangchao He (8194926), Zhaoxing Chu (7536365), Huanhuan Wu (339728), Junjie Wang (172690), Yiran Ge (8194932), Hui Shen (66625), Shan Zhang (431282), Jinxi Shan (11784280), Kewen Peng (8194929), Zhifeng Wei (11453658), Yi Zou (439002), Yungen Xu (1434802), Qihua Zhu (1555147)

مصطلحات موضوعية: Biochemistry, Medicine, Molecular Biology, Pharmacology, Biotechnology, Immunology, Cancer, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, unsatisfactory clinical efficacies, preliminary mechanistic studies, first inhibitor targeting, emerging evidence suggests, tumor immune escape, 144 nm ), selective ido1 inhibitors, first potent ido1, ido2 dual inhibitors, 2 dual inhibitors, selectively inhibiting ido1, 50 , 4t , inhibiting ido1, vivo <, vitro <, tumor immunotherapy, 28 nm, ido1 ic, synergistic effects, promising strategy

Relation: https://figshare.com/articles/dataset/Discovery_of_the_First_Potent_IDO1_IDO2_Dual_Inhibitors_A_Promising_Strategy_for_Cancer_Immunotherapy/17113534

الاتاحة: https://doi.org/10.1021/acs.jmedchem.1c01305.s002

المؤلفون: Xin He (48101), Guangchao He (8194926), Zhaoxing Chu (7536365), Huanhuan Wu (339728), Junjie Wang (172690), Yiran Ge (8194932), Hui Shen (66625), Shan Zhang (431282), Jinxi Shan (11784280), Kewen Peng (8194929), Zhifeng Wei (11453658), Yi Zou (439002), Yungen Xu (1434802), Qihua Zhu (1555147)

مصطلحات موضوعية: Biochemistry, Medicine, Molecular Biology, Pharmacology, Biotechnology, Immunology, Cancer, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, unsatisfactory clinical efficacies, preliminary mechanistic studies, first inhibitor targeting, emerging evidence suggests, tumor immune escape, 144 nm ), selective ido1 inhibitors, first potent ido1, ido2 dual inhibitors, 2 dual inhibitors, selectively inhibiting ido1, 50 , 4t , inhibiting ido1, vivo <, vitro <, tumor immunotherapy, 28 nm, ido1 ic, synergistic effects, promising strategy

Relation: https://figshare.com/articles/dataset/Discovery_of_the_First_Potent_IDO1_IDO2_Dual_Inhibitors_A_Promising_Strategy_for_Cancer_Immunotherapy/17113537

الاتاحة: https://doi.org/10.1021/acs.jmedchem.1c01305.s003